Mammalian brain consumption by blood donors in the United States: brains today, deferred tomorrow?
暂无分享,去创建一个
C. Nass | G. Schreiber | M. Busch | Y. Tu | G. Garratty | Ana M. Sánchez | M. Busch
[1] M. Woodford. Office International des Epizooties: World Organization for Animal Health , 2005 .
[2] J. MacKenzie,et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.
[3] K. Wilson,et al. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy. , 2003, Transfusion medicine reviews.
[4] P. Brown. Variant CJD transmission through blood: risks to predictors and “predictees” , 2003, Transfusion.
[5] M. Stoto. The precautionary principle and emerging biological risks: lessons from swine flu and HIV in blood products. , 2002, Public health reports.
[6] J. Kurland. The heart of the precautionary principle in democracy. , 2002, Public health reports.
[7] N. Hunter,et al. Transmission of prion diseases by blood transfusion. , 2002, The Journal of general virology.
[8] J. Tickner. Precautionary principle encourages policies that protect human health and the environment in the face of uncertain risks. , 2002, Public health reports.
[9] D. Dormont,et al. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus , 2002, Transfusion.
[10] M. Busch,et al. Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make , 2002, Transfusion.
[11] S. Glynn,et al. Knowledge of HIV/AIDS transmission and screening in United States blood donors , 2001, Transfusion.
[12] J. Collinge,et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.
[13] S. Glynn,et al. Repeat whole‐blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs , 2001, Transfusion.
[14] R. Dobson. Scientists show that vCJD can be transmitted through blood , 2000, BMJ : British Medical Journal.
[15] N. Hunter,et al. Transmission of BSE by blood transfusion in sheep , 2000, The Lancet.
[16] R. Somerville,et al. Infectivity in the blood of mice with a BSE-derived agent. , 2000, The Journal of hospital infection.
[17] S. Prusiner,et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] J Collinge,et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.
[19] S. Cousens,et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.
[20] Andrew F. Hill,et al. The same prion strain causes vCJD and BSE , 1997, Nature.
[21] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[22] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[23] C. Nass,et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods , 1995, Transfusion.
[24] J W Wilesmith,et al. Bovine spongiform encephalopathy: epidemiological studies on the origin , 1991, Veterinary Record.
[25] Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. , 2000, Releve epidemiologique hebdomadaire.